Barclays upgraded shares of Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF – Free Report) to a strong sell rating in a research report sent to investors on Tuesday, Zacks.com reports.
Separately, Royal Bank of Canada upgraded shares of Recordati Industria Chimica e Farmaceutica to a “hold” rating in a report on Monday, October 7th.
Check Out Our Latest Report on Recordati Industria Chimica e Farmaceutica
Recordati Industria Chimica e Farmaceutica Stock Performance
Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF – Get Free Report) last announced its earnings results on Tuesday, July 30th. The company reported $0.70 earnings per share (EPS) for the quarter. Recordati Industria Chimica e Farmaceutica had a return on equity of 30.78% and a net margin of 17.41%. The company had revenue of $622.00 million for the quarter.
About Recordati Industria Chimica e Farmaceutica
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.
See Also
- Five stocks we like better than Recordati Industria Chimica e Farmaceutica
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Monster and Celsius Energized: Which Stock Offers More Upside?
- Find and Profitably Trade Stocks at 52-Week Lows
- Sherwin-Williams Plunges Into Buying Opportunity: Time to Buy?
- Using the MarketBeat Dividend Yield Calculator
- Wolverine World Wide Breaks Out – Will the 92% Rally Continue?
Receive News & Ratings for Recordati Industria Chimica e Farmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Recordati Industria Chimica e Farmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.